Compound details
3-Dehydroteasterone
| Compound ID | CDAMM02639 |
|---|---|
| Common name | 3-Dehydroteasterone | IUPAC name | 17-(3,4-dihydroxy-5,6-dimethylheptan-2-yl)-10,13-dimethyl-2,4,5,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,6-dione |
| Molecular formula | C28H46O4 |
| Retention time | 6.41 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 447.344 | Theoretical mz | 447.347 |
| Error | 7.99 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 6.724 |
| Inchi key | SVBMASFUJDIDJC-UHFFFAOYNA-N |
|---|---|
| Smiles | O=C1CCC2(C)C(C(=O)CC3C4CCC(C(C)C(O)C(O)C(C)C(C)C)C4(C)CCC32)C1 |
| Superclass | Lipids and lipid-like molecules |
| Class | Steroids and steroid derivatives |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| P06241 | FYN | Tyrosine-protein kinase FYN | T17980 | SwissTargetPrediction |
| P11229 | CHRM1 | Muscarinic acetylcholine receptor M1 | T28893 | SwissTargetPrediction |
| P09874 | PARP1 | Poly [ADP-ribose] polymerase-1 | T06273 | SwissTargetPrediction |
| P47869 | GABRA2 | GABA A receptor alpha-2/beta-2/gamma-2 | T51452 | SwissTargetPrediction |
| O75899 | GABBR2 | GABA-B receptor | T42446 | SwissTargetPrediction |
| P42338 | PIK3CB | PI3-kinase p110-beta subunit | T05031 | SwissTargetPrediction |
| P42336 | PIK3CA | PI3-kinase p110-alpha subunit | T80276 | SwissTargetPrediction |
| P14416 | DRD2 | Dopamine D2 receptor | T67162 | SwissTargetPrediction |
| Q4U2R8 | SLC22A6 | Solute carrier family 22 member 6 (by homology) | T70680 | SwissTargetPrediction |
| Q96RI1 | NR1H4 | Bile acid receptor FXR | T51426 | SwissTargetPrediction |
| P17612 | PRKACA | cAMP-dependent protein kinase alpha-catalytic subunit | T12808 | SwissTargetPrediction |
| P31213 | SRD5A2 | Steroid 5-alpha-reductase 2 | T71390 | SEA |
| P34913 | EPHX2 | Epoxide hydratase | T35734 | SwissTargetPrediction |
| P42330 | AKR1C3 | Aldo-keto-reductase family 1 member C3 | T60857 | SwissTargetPrediction |
| P10275 | AR | Androgen Receptor | T11211 | SwissTargetPrediction and SEA |
| P45983 | MAPK8 | c-Jun N-terminal kinase 1 | T40097 | SwissTargetPrediction |
| P53779 | MAPK10 | c-Jun N-terminal kinase 3 | T85421 | SwissTargetPrediction |
| P35968 | KDR | Vascular endothelial growth factor receptor 2 | T80975 | SwissTargetPrediction |
| O75762 | TRPA1 | Transient receptor potential cation channel subfamily A member 1 | T84040 | SwissTargetPrediction |
| Q8NER1 | TRPV1 | Vanilloid receptor | T83193 | SwissTargetPrediction |
| P08185 | SERPINA6 | Corticosteroid binding globulin | T88452 | SwissTargetPrediction and SEA |
| O75469 | NR1I2 | Pregnane X receptor | T82702 | SwissTargetPrediction |
| P18405 | SRD5A1 | Steroid 5-alpha-reductase 1 | T70309 | SEA |
| P11511 | CYP19A1 | Cytochrome P450 19A1 | T13260 | SwissTargetPrediction |
| Q9UHC9 | NPC1L1 | Niemann-Pick C1-like protein 1 | T33901 | SwissTargetPrediction and SEA |
| O14684 | PTGES | Prostaglandin E synthase | T02562 | SwissTargetPrediction |
| P15090 | FABP4 | Fatty acid binding protein adipocyte | T07217 | SwissTargetPrediction |
| Q07869 | PPARA | Peroxisome proliferator-activated receptor alpha | T86591 | SwissTargetPrediction |
| Q01469 | FABP5 | Fatty acid binding protein epidermal | T21507 | SwissTargetPrediction |
| P30307 | CDC25C | Dual specificity phosphatase Cdc25C | T40569 | SwissTargetPrediction |
| P28845 | HSD11B1 | 11-beta-hydroxysteroid dehydrogenase 1 | T65200 | SwissTargetPrediction |
| P11473 | VDR | Vitamin D receptor | T34234 | SwissTargetPrediction |
| Q8TDU6 | GPBAR1 | G-protein coupled bile acid receptor 1 | T86273 | SwissTargetPrediction and SEA |
| P06746 | POLB | DNA polymerase beta (by homology) | T06958 | SwissTargetPrediction |
| P08254 | MMP3 | Matrix metalloproteinase 3 | T86702 | SwissTargetPrediction |
| P14780 | MMP9 | Matrix metalloproteinase 9 | T54156 | SwissTargetPrediction |
| P16662 | UGT2B7 | UDP-glucuronosyltransferase 2B7 | T62815 | SwissTargetPrediction |
| Q13133 | NR1H3 | LXR-alpha | T52297 | SEA |
| P03956 | MMP1 | Matrix metalloproteinase 1 | T52450 | SwissTargetPrediction |
| P35462 | DRD3 | Dopamine D3 receptor | T02551 | SwissTargetPrediction |
| P35372 | OPRM1 | Mu opioid receptor | T47768 | SwissTargetPrediction |
| P41145 | OPRK1 | Kappa Opioid receptor | T60693 | SwissTargetPrediction |
| P11309 | PIM1 | Serine/threonine-protein kinase PIM1 | T50594 | SwissTargetPrediction |
| P42345 | MTOR | Serine/threonine-protein kinase mTOR | T75243 | SwissTargetPrediction |
| Q16539 | MAPK14 | MAP kinase p38 alpha | T65864 | SwissTargetPrediction |
| P56817 | BACE1 | Beta-secretase 1 | T79031 | SwissTargetPrediction |
| O14965 | AURKA | Serine/threonine-protein kinase Aurora-A | T87675 | SwissTargetPrediction |
| Q9Y233 | PDE10A | Phosphodiesterase 10A (by homology) | T84133 | SwissTargetPrediction |
| P35270 | SPR | Substance-P receptor | T47094 | SwissTargetPrediction |
| P30559 | OXTR | Oxytocin receptor (by homology) | T84486 | SwissTargetPrediction |
| P37288 | AVPR1A | Vasopressin V1a receptor (by homology) | T79232 | SwissTargetPrediction |
| P41143 | OPRD1 | Delta opioid receptor | T58992 | SwissTargetPrediction |
| P49356 | FNTB | Farnesyl protein transferase | T13127 | SwissTargetPrediction |
| P80365 | HSD11B2 | 11-beta-hydroxysteroid dehydrogenase 2 | T43721 | SwissTargetPrediction |
| P11413 | G6PD | Glucose-6-phosphate 1-dehydrogenase | T63484 | SwissTargetPrediction |
| P05093 | CYP17A1 | Cytochrome P450 17A1 | T89041 | SEA |
| P32246 | CCR1 | C-C chemokine receptor type 1 | T16016 | SwissTargetPrediction |
| P05771 | PRKCB | Protein kinase C beta | T40276 | SwissTargetPrediction |
| Q02156 | PRKCE | Protein kinase C epsilon | T00895 | SwissTargetPrediction |
| P47871 | GCGR | Glucagon receptor | T60182 | SwissTargetPrediction |
| Q15858 | SCN9A | Sodium channel protein type IX alpha subunit | T12119 | SwissTargetPrediction |
| P49810 | PSEN2 | Gamma-secretase | T99204 | SwissTargetPrediction |
| P41229 | KDM5C | Lysine-specific demethylase 5C | T85540 | SwissTargetPrediction |
| Q14432 | PDE3A | Phosphodiesterase 3 | T88975 | SwissTargetPrediction |
| Q99572 | P2RX7 | P2X purinoceptor 7 | T63414 | SwissTargetPrediction |
| Q15078 | CDK5R1 | Cyclin-dependent kinase 5/CDK5 activator 1 | T09513 | SwissTargetPrediction |
| P12931 | SRC | Tyrosine-protein kinase SRC | T85943 | SwissTargetPrediction |
| Q13627 | DYRK1A | Dual-specificity tyrosine-phosphorylation regulated kinase 1A | T92803 | SwissTargetPrediction |
| P24385 | CCND1 | Cyclin-dependent kinase 4/cyclin D1 | T12355 | SwissTargetPrediction |
| P52333 | JAK3 | Tyrosine-protein kinase JAK3 | T23172 | SwissTargetPrediction |
| P48039 | MTNR1A | Melatonin receptor 1A | T97613 | SwissTargetPrediction |
| P49286 | MTNR1B | Melatonin receptor 1B | T48268 | SwissTargetPrediction |
| P34972 | CNR2 | Cannabinoid receptor 2 | T37693 | SwissTargetPrediction |
| O00311 | CDC7 | CDC7/DBF4 (Cell division cycle 7-related protein kinase/Activator of S phase kinase) | T81358 | SwissTargetPrediction |
| P28482 | MAPK1 | MAP kinase ERK2 | T58970 | SwissTargetPrediction |
| Q9Y2K7 | KDM2A | Lysine-specific demethylase 2A | T71949 | SwissTargetPrediction |
| P06737 | PYGL | Liver glycogen phosphorylase | T19184 | SwissTargetPrediction |
| P11597 | CETP | Cholesteryl ester transfer protein | T15334 | SwissTargetPrediction |
| Q00987 | MDM2 | p53-binding protein Mdm-2 | T00176 | SwissTargetPrediction |
| Q9UQM7 | CAMK2A | CaM kinase II alpha | T18299 | SwissTargetPrediction |
| Q96GD4 | AURKB | Serine/threonine-protein kinase Aurora-B | T46781 | SwissTargetPrediction |
| Q16584 | MAP3K11 | Mitogen-activated protein kinase kinase kinase 11 | T12126 | SwissTargetPrediction |
| P25116 | F2R | Proteinase-activated receptor 1 | T36483 | SwissTargetPrediction |
| P21452 | TACR2 | Neurokinin 2 receptor | T52790 | SwissTargetPrediction |
| Q05469 | LIPE | Hormone sensitive lipase | T55689 | SwissTargetPrediction |
| Q13370 | PDE3B | Phosphodiesterase 3B | T21357 | SwissTargetPrediction |
| Q16665 | HIF1A | Hypoxia-inducible factor 1 alpha | T55610 | SwissTargetPrediction |
| P40337 | VHL | Von Hippel-Lindau disease tumor suppressor/Elongin B/Elongin C | T80423 | SwissTargetPrediction |
| P40189 | IL6ST | Interleukin-6 receptor subunit beta | T93440 | SwissTargetPrediction |
| Q9UPP1 | PHF8 | Histone lysine demethylase PHF8 | T00933 | SwissTargetPrediction |
| Q99500 | S1PR3 | Sphingosine 1-phosphate receptor Edg-3 | T11241 | SwissTargetPrediction |
| Q9NRG4 | SMYD2 | N-lysine methyltransferase SMYD2 | T15797 | SwissTargetPrediction |
| P18507 | GABRG2 | GABA-A receptor; alpha-6/beta-3/gamma-2 | T08910 | SwissTargetPrediction |
| P47870 | GABRB2 | GABA(A) receptor beta-2 | T80387 | SwissTargetPrediction |
| O15439 | ABCC4 | Multidrug resistance protein 4 | T39919 | SEA |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T17980 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P06241 | FYN |
| T28893 | DI0001 | Abdominal pelvic pain | [ICD-11: MD81] | P11229 | CHRM1 |
| T28893 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P11229 | CHRM1 |
| T28893 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | P11229 | CHRM1 |
| T28893 | DI0129 | Dystonic disorder | [ICD-11: 8A02] | P11229 | CHRM1 |
| T28893 | DI0154 | Functional bladder disorder | [ICD-11: GC50] | P11229 | CHRM1 |
| T28893 | DI0157 | Gastric ulcer | [ICD-11: DA60] | P11229 | CHRM1 |
| T28893 | DI0166 | Glaucoma | [ICD-11: 9C61] | P11229 | CHRM1 |
| T28893 | DI0186 | Hyperhidrosis | [ICD-11: EE00] | P11229 | CHRM1 |
| T28893 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | P11229 | CHRM1 |
| T28893 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P11229 | CHRM1 |
| T28893 | DI0333 | Peptic ulcer | [ICD-11: DA61] | P11229 | CHRM1 |
| T28893 | DI0371 | Sebaceous gland disorder | [ICD-11: ED91] | P11229 | CHRM1 |
| T06273 | DI0006 | Acquired cutaneous blood vessel malformation | [ICD-11: EF20] | P09874 | PARP1 |
| T06273 | DI0143 | Fallopian tube cancer | [ICD-11: 2C74] | P09874 | PARP1 |
| T06273 | DI0321 | Ovarian cancer | [ICD-11: 2C73] | P09874 | PARP1 |
| T06273 | DI0334 | Peritoneal cancer | [ICD-11: 2C51] | P09874 | PARP1 |
| T51452 | DI0216 | Intentional self-harm | [ICD-11: PC91] | P47869 | GABRA2 |
| T42446 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | O75899 | GABBR2 |
| T42446 | DI0134 | Epilepsy/seizure | [ICD-11: 8A61-8A6Z] | O75899 | GABBR2 |
| T42446 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | O75899 | GABBR2 |
| T42446 | DI0290 | Narcolepsy | [ICD-11: 7A20] | O75899 | GABBR2 |
| T05031 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P42338 | PIK3CB |
| T80276 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P42336 | PIK3CA |
| T80276 | DI0151 | Follicular lymphoma | [ICD-11: 2A80] | P42336 | PIK3CA |
| T80276 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P42336 | PIK3CA |
| T67162 | DI0022 | Allergic/hypersensitivity disorder | [ICD-11: 4A80-4A8Z] | P14416 | DRD2 |
| T67162 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P14416 | DRD2 |
| T67162 | DI0037 | Asthma | [ICD-11: CA23] | P14416 | DRD2 |
| T67162 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | P14416 | DRD2 |
| T67162 | DI0051 | Bipolar disorder | [ICD-11: 6A60] | P14416 | DRD2 |
| T67162 | DI0063 | Breathing abnormality | [ICD-11: MD11] | P14416 | DRD2 |
| T67162 | DI0070 | Cardiovascular disease | [ICD-11: BA00-BE2Z] | P14416 | DRD2 |
| T67162 | DI0073 | Cerebral ischaemia | [ICD-11: 8B1Z] | P14416 | DRD2 |
| T67162 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P14416 | DRD2 |
| T67162 | DI0124 | Digestive system disease | [ICD-11: DE2Z] | P14416 | DRD2 |
| T67162 | DI0137 | Essential hypertension | [ICD-11: BA00] | P14416 | DRD2 |
| T67162 | DI0142 | Faecal incontinence | [ICD-11: ME07] | P14416 | DRD2 |
| T67162 | DI0156 | Gangrene | [ICD-11: MC85] | P14416 | DRD2 |
| T67162 | DI0166 | Glaucoma | [ICD-11: 9C61] | P14416 | DRD2 |
| T67162 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P14416 | DRD2 |
| T67162 | DI0185 | Hyperaemia | [ICD-11: 9A61-9B7Y] | P14416 | DRD2 |
| T67162 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P14416 | DRD2 |
| T67162 | DI0196 | Hypotension | [ICD-11: BA20-BA21] | P14416 | DRD2 |
| T67162 | DI0205 | Inborn porphyrin/heme metabolism error | [ICD-11: 5C58] | P14416 | DRD2 |
| T67162 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P14416 | DRD2 |
| T67162 | DI0222 | Itching | [ICD-11: 1F28-1G07] | P14416 | DRD2 |
| T67162 | DI0264 | Migraine | [ICD-11: 8A80] | P14416 | DRD2 |
| T67162 | DI0293 | Nausea/vomiting | [ICD-11: MD90] | P14416 | DRD2 |
| T67162 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P14416 | DRD2 |
| T67162 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P14416 | DRD2 |
| T67162 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P14416 | DRD2 |
| T67162 | DI0340 | Postpartum haemorrhage | [ICD-11: JA43] | P14416 | DRD2 |
| T67162 | DI0354 | Psychotic disorder | [ICD-11: 6A20-6A25] | P14416 | DRD2 |
| T67162 | DI0356 | Pulmonary hypertension | [ICD-11: BB01] | P14416 | DRD2 |
| T67162 | DI0370 | Schizophrenia | [ICD-11: 6A20] | P14416 | DRD2 |
| T67162 | DI0396 | Substance abuse | [ICD-11: 6C40] | P14416 | DRD2 |
| T67162 | DI0408 | Thyrotoxicosis | [ICD-11: 5A02] | P14416 | DRD2 |
| T67162 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P14416 | DRD2 |
| T70680 | DI0167 | Gout | [ICD-11: FA25] | Q4U2R8 | SLC22A6 |
| T70680 | DI0206 | Inborn purine/pyrimidine/nucleotide metabolism error | [ICD-11: 5C55] | Q4U2R8 | SLC22A6 |
| T70680 | DI0310 | Ocular disease | [ICD-11: N.A.] | Q4U2R8 | SLC22A6 |
| T51426 | DI0043 | Autoimmune liver disease | [ICD-11: DB96] | Q96RI1 | NR1H4 |
| T51426 | DI0077 | Cholelithiasis | [ICD-11: DC11] | Q96RI1 | NR1H4 |
| T51426 | DI0320 | Osteoarthritis | [ICD-11: FA00-FA05] | Q96RI1 | NR1H4 |
| T12808 | DI0279 | Muscular atrophy | [ICD-11: 8B61] | P17612 | PRKACA |
| T71390 | DI0348 | Prostate hyperplasia | [ICD-11: GA90] | P31213 | SRD5A2 |
| T35734 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P34913 | EPHX2 |
| T35734 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P34913 | EPHX2 |
| T60857 | DI0145 | Female pelvic pain | [ICD-11: GA34] | P42330 | AKR1C3 |
| T11211 | DI0005 | Acne vulgaris | [ICD-11: ED80] | P10275 | AR |
| T11211 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P10275 | AR |
| T11211 | DI0021 | Alcoholic liver disease | [ICD-11: DB94] | P10275 | AR |
| T11211 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P10275 | AR |
| T11211 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P10275 | AR |
| T11211 | DI0145 | Female pelvic pain | [ICD-11: GA34] | P10275 | AR |
| T11211 | DI0194 | Hypo-osmolality/hyponatraemia | [ICD-11: 5C72] | P10275 | AR |
| T11211 | DI0237 | Low bone mass disorder | [ICD-11: FB83] | P10275 | AR |
| T11211 | DI0247 | Mammary tumour | [ICD-11: 2C60-2C6Z] | P10275 | AR |
| T11211 | DI0346 | Prostate cancer | [ICD-11: 2C82] | P10275 | AR |
| T11211 | DI0401 | Testicular dysfunction | [ICD-11: 5A81] | P10275 | AR |
| T40097 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P45983 | MAPK8 |
| T85421 | DI0125 | Dissociative neurological symptom disorder | [ICD-11: 6B60] | P53779 | MAPK10 |
| T80975 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P35968 | KDR |
| T80975 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | P35968 | KDR |
| T80975 | DI0160 | Gastrointestinal stromal tumour | [ICD-11: 2B5B] | P35968 | KDR |
| T80975 | DI0244 | Malignant digestive organ neoplasm | [ICD-11: 2C11] | P35968 | KDR |
| T80975 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P35968 | KDR |
| T80975 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P35968 | KDR |
| T80975 | DI0395 | Stomach cancer | [ICD-11: 2B72] | P35968 | KDR |
| T80975 | DI0403 | Thrombocytopenia | [ICD-11: 3B64] | P35968 | KDR |
| T80975 | DI0407 | Thyroid cancer | [ICD-11: 2D10] | P35968 | KDR |
| T84040 | DI0422 | Upper respiratory tract disorder | [ICD-11: CA0Z] | O75762 | TRPA1 |
| T83193 | DI0163 | General pain disorder | [ICD-11: 8E43] | Q8NER1 | TRPV1 |
| T88452 | DI0037 | Asthma | [ICD-11: CA23] | P08185 | SERPINA6 |
| T88452 | DI0339 | Postoperative inflammation | [ICD-11: 1A00-CA43] | P08185 | SERPINA6 |
| T88452 | DI0362 | Respiratory system disease | [ICD-11: CB40-CB7Z] | P08185 | SERPINA6 |
| T70309 | DI0347 | Prostate disease | [ICD-11: GA91] | P18405 | SRD5A1 |
| T13260 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P11511 | CYP19A1 |
| T13260 | DI0108 | Cushing syndrome | [ICD-11: 5A70] | P11511 | CYP19A1 |
| T33901 | DI0188 | Hyper-lipoproteinaemia | [ICD-11: 5C80] | Q9UHC9 | NPC1L1 |
| T02562 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | O14684 | PTGES |
| T86591 | DI0187 | Hyperlipidemia | [ICD-11: 5C80] | Q07869 | PPARA |
| T86591 | DI0188 | Hyper-lipoproteinaemia | [ICD-11: 5C80] | Q07869 | PPARA |
| T86591 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | Q07869 | PPARA |
| T65200 | DI0210 | Influenza | [ICD-11: 1E30-1E32] | P28845 | HSD11B1 |
| T65200 | DI0239 | Lupus erythematosus | [ICD-11: 4A40] | P28845 | HSD11B1 |
| T65200 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P28845 | HSD11B1 |
| T34234 | DI0083 | Chronic kidney disease | [ICD-11: GB61] | P11473 | VDR |
| T34234 | DI0171 | Hair/hair growth developmental defect | [ICD-11: LC30] | P11473 | VDR |
| T34234 | DI0189 | Hyper-parathyroidism | [ICD-11: 5A51] | P11473 | VDR |
| T34234 | DI0195 | Hypo-parathyroidism | [ICD-11: 5A50] | P11473 | VDR |
| T34234 | DI0266 | Mineral deficiency | [ICD-11: 5B5K] | P11473 | VDR |
| T34234 | DI0351 | Psoriasis | [ICD-11: EA90] | P11473 | VDR |
| T34234 | DI0437 | Vitamin deficiency | [ICD-11: 5B55-5B5F] | P11473 | VDR |
| T86273 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | Q8TDU6 | GPBAR1 |
| T06958 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P06746 | POLB |
| T86702 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | P08254 | MMP3 |
| T86702 | DI0179 | Hepatitis virus infection | [ICD-11: 1E50-1E51] | P08254 | MMP3 |
| T86702 | DI0199 | Idiopathic interstitial pneumonitis | [ICD-11: CB03] | P08254 | MMP3 |
| T86702 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | P08254 | MMP3 |
| T86702 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | P08254 | MMP3 |
| T86702 | DI0320 | Osteoarthritis | [ICD-11: FA00-FA05] | P08254 | MMP3 |
| T86702 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P08254 | MMP3 |
| T54156 | DI0219 | Ischaemic/haemorrhagic stroke | [ICD-11: 8B20] | P14780 | MMP9 |
| T54156 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P14780 | MMP9 |
| T54156 | DI0395 | Stomach cancer | [ICD-11: 2B72] | P14780 | MMP9 |
| T54156 | DI0419 | Ulcerative colitis | [ICD-11: DD71] | P14780 | MMP9 |
| T52297 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | Q13133 | NR1H3 |
| T52450 | DI0238 | Lung cancer | [ICD-11: 2C25] | P03956 | MMP1 |
| T02551 | DI0051 | Bipolar disorder | [ICD-11: 6A60] | P35462 | DRD3 |
| T02551 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P35462 | DRD3 |
| T47768 | DI0013 | Acute pain | [ICD-11: MG31] | P35372 | OPRM1 |
| T47768 | DI0059 | Bowel habit change | [ICD-11: ME05] | P35372 | OPRM1 |
| T47768 | DI0087 | Chronic pain | [ICD-11: MG30] | P35372 | OPRM1 |
| T47768 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | P35372 | OPRM1 |
| T47768 | DI0105 | Cough | [ICD-11: MD12] | P35372 | OPRM1 |
| T47768 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P35372 | OPRM1 |
| T47768 | DI0124 | Digestive system disease | [ICD-11: DE2Z] | P35372 | OPRM1 |
| T47768 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | P35372 | OPRM1 |
| T47768 | DI0228 | Large intestine motility disorder | [ICD-11: DB32] | P35372 | OPRM1 |
| T47768 | DI0317 | Opioid use disorder | [ICD-11: 6C43] | P35372 | OPRM1 |
| T47768 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P35372 | OPRM1 |
| T47768 | DI0349 | Pruritus | [ICD-11: EC90] | P35372 | OPRM1 |
| T47768 | DI0374 | Sensation disturbance | [ICD-11: MB40] | P35372 | OPRM1 |
| T60693 | DI0304 | Non-specific cutaneous vascular symptom | [ICD-11: ME64] | P41145 | OPRK1 |
| T60693 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P41145 | OPRK1 |
| T60693 | DI0349 | Pruritus | [ICD-11: EC90] | P41145 | OPRK1 |
| T50594 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P11309 | PIM1 |
| T50594 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P11309 | PIM1 |
| T75243 | DI0036 | Arteries/arterioles disorder | [ICD-11: BD52] | P42345 | MTOR |
| T75243 | DI0085 | Chronic myelomonocytic leukaemia | [ICD-11: 2A40] | P42345 | MTOR |
| T75243 | DI0274 | Multiple myeloma | [ICD-11: 2A83] | P42345 | MTOR |
| T75243 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P42345 | MTOR |
| T75243 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P42345 | MTOR |
| T75243 | DI0413 | Transplant rejection | [ICD-11: NE84] | P42345 | MTOR |
| T65864 | DI0102 | Coronary atherosclerosis | [ICD-11: BA52] | Q16539 | MAPK14 |
| T65864 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | Q16539 | MAPK14 |
| T65864 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | Q16539 | MAPK14 |
| T65864 | DI0437 | Vitamin deficiency | [ICD-11: 5B55-5B5F] | Q16539 | MAPK14 |
| T79031 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P56817 | BACE1 |
| T87675 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | O14965 | AURKA |
| T87675 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | O14965 | AURKA |
| T84133 | DI0079 | Choreiform disorder | [ICD-11: 8A01] | Q9Y233 | PDE10A |
| T84133 | DI0206 | Inborn purine/pyrimidine/nucleotide metabolism error | [ICD-11: 5C55] | Q9Y233 | PDE10A |
| T84133 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | Q9Y233 | PDE10A |
| T84133 | DI0370 | Schizophrenia | [ICD-11: 6A20] | Q9Y233 | PDE10A |
| T84133 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9Y233 | PDE10A |
| T47094 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P35270 | SPR |
| T47094 | DI0293 | Nausea/vomiting | [ICD-11: MD90] | P35270 | SPR |
| T84486 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P30559 | OXTR |
| T84486 | DI0041 | Autism spectrum disorder | [ICD-11: 6A02] | P30559 | OXTR |
| T84486 | DI0340 | Postpartum haemorrhage | [ICD-11: JA43] | P30559 | OXTR |
| T79232 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P37288 | AVPR1A |
| T79232 | DI0041 | Autism spectrum disorder | [ICD-11: 6A02] | P37288 | AVPR1A |
| T79232 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P37288 | AVPR1A |
| T79232 | DI0194 | Hypo-osmolality/hyponatraemia | [ICD-11: 5C72] | P37288 | AVPR1A |
| T79232 | DI0236 | Localisation | [ICD-11: N.A.] | P37288 | AVPR1A |
| T58992 | DI0059 | Bowel habit change | [ICD-11: ME05] | P41143 | OPRD1 |
| T58992 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | P41143 | OPRD1 |
| T58992 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P41143 | OPRD1 |
| T13127 | DI0342 | Premature ageing appearance | [ICD-11: LD2B] | P49356 | FNTB |
| T43721 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P80365 | HSD11B2 |
| T63484 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P11413 | G6PD |
| T89041 | DI0346 | Prostate cancer | [ICD-11: 2C82] | P05093 | CYP17A1 |
| T16016 | DI0120 | Diabetes mellitus | [ICD-11: 5A10] | P32246 | CCR1 |
| T16016 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P32246 | CCR1 |
| T40276 | DI0123 | Diffuse large B-cell lymphoma | [ICD-11: 2A81] | P05771 | PRKCB |
| T40276 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | P05771 | PRKCB |
| T40276 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P05771 | PRKCB |
| T00895 | DI0033 | Anxiety disorder | [ICD-11: 6B00-6B0Z] | Q02156 | PRKCE |
| T00895 | DI0243 | Malaria | [ICD-11: 1F40-1F45] | Q02156 | PRKCE |
| T60182 | DI0193 | Hypo-glycaemia | [ICD-11: 5A41] | P47871 | GCGR |
| T12119 | DI0051 | Bipolar disorder | [ICD-11: 6A60] | Q15858 | SCN9A |
| T12119 | DI0087 | Chronic pain | [ICD-11: MG30] | Q15858 | SCN9A |
| T12119 | DI0140 | Extremities vasodilatation | [ICD-11: EG00] | Q15858 | SCN9A |
| T12119 | DI0163 | General pain disorder | [ICD-11: 8E43] | Q15858 | SCN9A |
| T12119 | DI0320 | Osteoarthritis | [ICD-11: FA00-FA05] | Q15858 | SCN9A |
| T12119 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | Q15858 | SCN9A |
| T12119 | DI0358 | Radiculopathy | [ICD-11: 8B93] | Q15858 | SCN9A |
| T12119 | DI0415 | Trigeminal nerve disorder | [ICD-11: 8B82] | Q15858 | SCN9A |
| T99204 | DI0320 | Osteoarthritis | [ICD-11: FA00-FA05] | P49810 | PSEN2 |
| T99204 | DI0380 | Shoulder lesion | [ICD-11: FB53] | P49810 | PSEN2 |
| T99204 | DI0390 | Soft tissue disorder | [ICD-11: FB56] | P49810 | PSEN2 |
| T88975 | DI0035 | Arterial occlusive disease | [ICD-11: BD40] | Q14432 | PDE3A |
| T88975 | DI0037 | Asthma | [ICD-11: CA23] | Q14432 | PDE3A |
| T88975 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | Q14432 | PDE3A |
| T88975 | DI0404 | Thrombocytosis | [ICD-11: 3B63] | Q14432 | PDE3A |
| T63414 | DI0224 | Joint pain | [ICD-11: ME82] | Q99572 | P2RX7 |
| T85943 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P12931 | SRC |
| T85943 | DI0220 | Ischemia | [ICD-11: 8B10-8B11] | P12931 | SRC |
| T85943 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P12931 | SRC |
| T85943 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P12931 | SRC |
| T92803 | DI0113 | Cytomegaloviral disease | [ICD-11: 1D82] | Q13627 | DYRK1A |
| T12355 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P24385 | CCND1 |
| T23172 | DI0023 | Alopecia | [ICD-11: ED70] | P52333 | JAK3 |
| T23172 | DI0039 | Atopic eczema | [ICD-11: EA80] | P52333 | JAK3 |
| T23172 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P52333 | JAK3 |
| T23172 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P52333 | JAK3 |
| T97613 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P48039 | MTNR1A |
| T48268 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P49286 | MTNR1B |
| T37693 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | P34972 | CNR2 |
| T37693 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P34972 | CNR2 |
| T81358 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | O00311 | CDC7 |
| T81358 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | O00311 | CDC7 |
| T58970 | DI0036 | Arteries/arterioles disorder | [ICD-11: BD52] | P28482 | MAPK1 |
| T58970 | DI0252 | Melanoma | [ICD-11: 2C30] | P28482 | MAPK1 |
| T58970 | DI0326 | Pancreatic cancer | [ICD-11: 2C10] | P28482 | MAPK1 |
| T58970 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P28482 | MAPK1 |
| T15334 | DI0035 | Arterial occlusive disease | [ICD-11: BD40] | P11597 | CETP |
| T15334 | DI0070 | Cardiovascular disease | [ICD-11: BA00-BE2Z] | P11597 | CETP |
| T15334 | DI0188 | Hyper-lipoproteinaemia | [ICD-11: 5C80] | P11597 | CETP |
| T15334 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | P11597 | CETP |
| T00176 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | Q00987 | MDM2 |
| T00176 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q00987 | MDM2 |
| T18299 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | Q9UQM7 | CAMK2A |
| T46781 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | Q96GD4 | AURKB |
| T46781 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q96GD4 | AURKB |
| T36483 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | P25116 | F2R |
| T52790 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | P21452 | TACR2 |
| T55689 | DI0332 | Pediculosis | [ICD-11: 1G00] | Q05469 | LIPE |
| T55610 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | Q16665 | HIF1A |
| T55610 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q16665 | HIF1A |
| T93440 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P40189 | IL6ST |
| T11241 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | Q99500 | S1PR3 |
| T15797 | DI0238 | Lung cancer | [ICD-11: 2C25] | Q9NRG4 | SMYD2 |
| T15797 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9NRG4 | SMYD2 |
| T08910 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P18507 | GABRG2 |
| T08910 | DI0256 | Mental/behavioural/neurodevelopmental disorder | [ICD-11: 6E20-6E8Z] | P18507 | GABRG2 |
| T08910 | DI0411 | Tonus and reflex abnormality | [ICD-11: MB47] | P18507 | GABRG2 |
| T80387 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P47870 | GABRB2 |
| T80387 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P47870 | GABRB2 |
| T80387 | DI0256 | Mental/behavioural/neurodevelopmental disorder | [ICD-11: 6E20-6E8Z] | P47870 | GABRB2 |
| T80387 | DI0411 | Tonus and reflex abnormality | [ICD-11: MB47] | P47870 | GABRB2 |